Journal Home > Volume 11 , Issue 1

Foxtail millet (FM) whole grain has received special attention in recent years. To confirm the hypoglycemic effects of FM, we investigated the effects of FM supplementation on glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin (HFD/STZ)-induced diabetes. Specifically, we fully assessed the blood biochemical profiles, pancreatic histopathology, insulin-glucagon immunofluorescence, short-chain fatty acids, and gut microbiota composition of rats with HFD/STZ-induced diabetes before and after FM supplementation. Results showed that both 30% and 48% FM supplementation significantly decreased concentrations of fasting blood glucose, 60-min blood glucose, and blood triglycerides (P < 0.05); additionally, 48% FM supplementation significantly improved blood glucose tolerance and insulin resistance (P < 0.05). However, FM supplementation could not effectively repair damage to β-cells over a short period of time. In addition, 4 weeks of 48% FM supplementation siginificantly increased the relative abundance of Bifidobacterium and concentration of butyrate, suggesting that the hypoglycemic effects of FM supplementation might be partially mediated by gut microbiota. Collectively, we found a dose-dependent relationship between FM supplementation and improvement of blood glucose metabolism, but did not find a synergistic effect between FM supplementation and metformin (Met) treatment. Our findings provide further support that consuming more whole-grain FM might be beneficial to individuals suffering from type 2 diabetes.


menu
Abstract
Full text
Outline
About this article

Foxtail millet supplementation improves glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin-induced diabetes

Show Author's information Xin Rena,bLinxuan WangaZenglong ChencMin ZhangaDianzhi HoubYong XuebXianmin DiaodRuihai LiueQun Shenb( )
Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Engineering and Technology Research Center of Food Additives, Beijing Technology and Business University, Beijing 100048, China
Key Laboratory of Plant Protein and Grain processing, National Engineering and Technology Research Center for Fruits and Vegetables, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China
State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
Chinese Academy of Agricultural Sciences, Beijing 100081, China
Institute of Comparative and Environmental Toxicology, Department of Food Science, Cornell University, Ithaca, NY, United States

Abstract

Foxtail millet (FM) whole grain has received special attention in recent years. To confirm the hypoglycemic effects of FM, we investigated the effects of FM supplementation on glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin (HFD/STZ)-induced diabetes. Specifically, we fully assessed the blood biochemical profiles, pancreatic histopathology, insulin-glucagon immunofluorescence, short-chain fatty acids, and gut microbiota composition of rats with HFD/STZ-induced diabetes before and after FM supplementation. Results showed that both 30% and 48% FM supplementation significantly decreased concentrations of fasting blood glucose, 60-min blood glucose, and blood triglycerides (P < 0.05); additionally, 48% FM supplementation significantly improved blood glucose tolerance and insulin resistance (P < 0.05). However, FM supplementation could not effectively repair damage to β-cells over a short period of time. In addition, 4 weeks of 48% FM supplementation siginificantly increased the relative abundance of Bifidobacterium and concentration of butyrate, suggesting that the hypoglycemic effects of FM supplementation might be partially mediated by gut microbiota. Collectively, we found a dose-dependent relationship between FM supplementation and improvement of blood glucose metabolism, but did not find a synergistic effect between FM supplementation and metformin (Met) treatment. Our findings provide further support that consuming more whole-grain FM might be beneficial to individuals suffering from type 2 diabetes.

Keywords: Gut microbiota, Glucose metabolism, Short-chain fatty acids, Foxtail millet

References(48)

[1]

A.B. Evert, J.L. Boucher, M. Cypress, et al., Nutrition therapy recommendations for the management of adults with diabetes, Diabetes Care 37(Supplement 1) (2014) S120–S143. https://doi.org/10.2337/dc14-S120.

[2]

A.A Diabet, Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association, Diabetes Care 33(8) (2010) 1911. https://doi.org/10.2337/dc10-er08a.

[3]

M. Chandalia, A. Garg, D. Lutjohann, et al., Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus, New Engl. J. Med. 342(19) (2000) 1392–1398. https://doi.org/10.1056/NEJM200005113421903.

[4]

J. Montonen, P. Knekt, R. Järvinen, et al., Whole-grain and fiber intake and the incidence of type 2 diabetes, Am. J. Clin. Nutr. 77(3) (2003) 622–629. https://doi.org/10.1093/ajcn/77.3.622.

[5]

P. Xi, R.H. Liu, Whole food approach for type 2 diabetes prevention, Mol. Nutr. Food Res. 60(8) (2016) 1819–1836. https://doi.org/10.1002/mnfr.201500963.

[6]

S.H. Ley, O. Hamdy, V. Mohan, et al., Prevention and management of type 2 diabetes: dietary components and nutritional strategies, Lancet 383(9933) (2014) 1999–2007. https://doi.org/10.1016/S0140-6736(14)60613-9.

[7]

Y. Hu, M. Ding, L. Sampson, et al., Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies, BMJ (Clinical research ed) 370 (2020) m2206. https://doi.org/10.1136/bmj.m2206.

[8]

C.D. Society, Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition), Chin. J. Pract. Intern. Med. 38(4) (2018) 34–86. https://doi.org/10.19538/j.nk2018040108.

[9]

A.S. Saleh, Q. Zhang, J. Chen, et al., Millet grains: nutritional quality, processing, and potential health benefits, Compr. Rev. Food Sci. Food Saf. 12(3) (2013) 281–295. https://doi.org/10.1111/1541-4337.12012.

[10]

Y.Y. Choi, K. Osada, Y. Ito, et al., Effects of dietary protein of Korean foxtail millet on plasma adiponectin, HDL-cholesterol, and insulin levels in genetically type 2 diabetic mice, Biosci. Biotech. Bioch. 69(1) (2005) 31–37. https://doi.org/10.1271/bbb.69.31.

[11]

J.L. Dong, L. Wang, J. Lu, et al., Structural, antioxidant and adsorption properties of dietary fiber from foxtail millet (Setaria italica) bran, J. Sci. Food Agric. 99(8) (2019) 3886–3894. https://doi.org/10.1002/jsfa.9611.

[12]

L.Z. Zhang, R.H. Liu, Phenolic and carotenoid profiles and antiproliferative activity of foxtail millet, Food Chem. 174 (2015) 495–501. https://doi.org/10.1016/j.foodchem.2014.09.089.

[13]

X. Ren, J. Chen, M.M. Molla, et al., In vitro starch digestibility and in vivo glycemic response of foxtail millet and its products, Food Funct. 7(1) (2016) 372–379. https://doi.org/10.1039/C5FO01074H.

[14]

X. Ren, J. Chen, C. Wang, et al., In vitro starch digestibility, degree of gelatinization and estimated glycemic index of foxtail millet-derived products: effect of freezing and frozen storage, J. Cereal Sci. 69 (2016) 166–173. https://doi.org/10.1016/j.jcs.2016.03.007.

[15]

X. Ren, R. Yin, D. Hou, et al., The glucose-lowering effect of foxtail millet in subjects with impaired glucose tolerance: a self-controlled clinical trial, Nutrients 10 (2018) 1509. https://doi.org/10.3390/nu10101509.

[16]

J. Qin, Y. Li, Z. Cai, et al., A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature 490(7418) (2012) 55–60. https://doi.org/10.1038/nature11450.

[17]

M. Gurung, Z. Li, H. You, et al., Role of gut microbiota in type 2 diabetes pathophysiology, Ebiomedicine 51 (2020). https://doi.org/10.1016/j.ebiom.2019.11.051.

[18]

K. Makki, E.C. Deehan, J. Walter, et al., The impact of dietary fiber on gut microbiota in host health and disease, Cell Host Microbe. 23(6) (2018) 705–715. https://doi.org/10.1016/j.chom.2018.05.012.

[19]

D. Houghton, T. Hardy, C. Stewart, et al., Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes, Diabetologia 61(8) (2018) 1700–1711. https://doi.org/10.1007/s00125-018-4632-0.

[20]

C.G. Zhang, W.J. Gong, Z.H. Li, et al., Research progress of gut flora in improving human wellness, Food Sci. Human Wellness 8(2) (2019) 102–105. https://doi.org/10.1016/j.fshw.2019.03.007.

[21]

F. Han, Y. Wang, Y. Han, et al., Effects of whole-grain rice and wheat on composition of gut microbiota and short-chain fatty acids in rats, J. Agric. Food Chem. 66(25) (2018) 6326–6335. https://doi.org/10.1021/acs.jafc.8b01891.

[22]

R. Yang, S. Shan, C. Zhang, et al., Inhibitory effects of bound polyphenol from foxtail millet bran on colitis-associated carcinogenesis by the restoration of gut microbiota in a mice model, J. Agric. Food Chem. 68(11) (2020) 3506–3517. https://doi.org/10.1021/acs.jafc.0c00370.

[23]

K. Srinivasan, B. Viswanad, L. Asrat, et al., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening, Pharmacol. Res. 52(4) (2005) 313–320. https://doi.org/10.1016/j.phrs.2005.05.004.

[24]

S.S. Wang, S. Lay, H.N. Yu, et al., Dietary guidelines for chinese residents (2016): comments and comparisons, J. Zhejiang Univ. Sci. B 17(9) (2016) 649-656. https://doi.org/10.1631/jzus.B1600341.

[25]

J.T. Cheng, C.C. Huang, I.M. Liu, et al., Novel mechanism for plasma glucose–lowering action of metformin in streptozotocin-induced diabetic rats, Diabetes 55(3) (2006) 819–825. https://doi.org/10.2337/diabetes.55.03.06. db05-0934.

[26]

D.R. Matthews, J.P. Hosker, A.S. Rudenski, et al., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 28(7) (1985) 412–419. https://doi.org/10.1007/BF00280883.

[27]

H. Hao, J. Liu, J. Shen, et al., Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats, Biochem. Biophysi. Res. Commun. 436(3) (2013) 418–423. https://doi.org/10.1016/j.bbrc.2013.05.117.

[28]

G. Zhao, M. Nyman, J.Å. Jönsson. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified waterextraction and direct-injection gas chromatography, Biomed. Chromatogr. 20(8) (2006) 674–682. https://doi.org/10.1002/bmc.580.

[29]

P. Saeedi, I. Petersohn, P. Salpea, et al., Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition, Diabetes Res. Clin Pract. 157 (2019) 10. https://doi.org/10.1016/j.diabres.2019.107843.

[30]

L. Zhu, Z.G. She, X. Cheng, et al., Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes, Cell Metab. 31(6) (2020) 1068. https://doi.org/10.1016/j.cmet.2020.04.021.

[31]

B. Sharma, H.S. Gujral. Modulation in quality attributes of dough and starch digestibility of unleavened flat bread on replacing wheat flour with different minor millet flours, Int. J. Biol. Macromol. 141 (2019) 117–124. https://doi.org/10.1016/j.ijbiomac.2019.08.252.

[32]

P.M. Pradeep, Y.N. Sreerama. Phenolic antioxidants of foxtail and little millet cultivars and their inhibitory effects on alpha-amylase and alpha-glucosidase activities, Food Chem. 247 (2018) 46–55. https://doi.org/10.1016/j.foodchem.2017.11.103.

[33]

M. Karás, A. Jakubczyk, U. Szymanowska, et al., Different temperature treatments of millet grains affect the biological activity of protein hydrolyzates and peptide fractions, Nutrients 11(3) (2019) 21. https://doi.org/10.3390/nu11030550.

[34]

N. Nishizawa, T. Togawa, K.O. Park, et al., Dietary Japanese millet protein ameliorates plasma levels of adiponectin, glucose, and lipids in type 2 diabetic mice, Biosci. Biotech. Bioch. 73(2) (2009) 351–360. https://doi.org/10.1271/bbb.80589.

[35]

K.O. Park, Y. Ito, T. Nagasawa, et al., Effects of dietary Korean proso-millet protein on plasma adiponectin, HDL cholesterol, insulin levels, and gene expression in obese type 2 diabetic mice, Biosci. Biotech. Bioch. 72(11) (2008) 2918. https://doi.org/10.1271/bbb.80395.

[36]

S. Li, W. Yu, X. Guan, et al., Effects of millet whole grain supplementation on the lipid profile and gut bacteria in rats fed with high-fat diet. J. Funct. Foods, 59 (2019) 49–59. https://doi.org/10.1016/j.jff.2019.05.030.

[37]

S. Talukder, B.D. Sharma. Scope of millet grains as an extender in meat products, Crit. Rev. Food Sci. Nutr. 55(6) (2015) 735–739. https://doi.org/10.1080/10408398.2012.674072.

[38]

A.X. Zhang, X.D. Liu, G.R. Wang, et al., Crude fat content and fatty acid profile and their correlations in foxtail millet, Cereal Chem. 92(5) (2015) 455–459. https://doi.org/10.1094/cchem-12-14-0252-r.

[39]

C.R. Sirtori, G. Crepaldi, E. Manzato, et al., One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations, Atherosclerosis 137(2) (1998) 419–427. https://doi.org/10.1016/S0021-9150(97)00298-0.

[40]

R.A. Reimer, G.J. Grover, L. Koetzner, et al., The soluble fiber complex PolyGlycopleX lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed rats, Nutr. Res. 31(4) (2011) 296–301. https://doi.org/10.1016/j.nutres.2011.03.012.

[41]

H.C. Lee, S.C. Yu, Y.C. Lo, et al., A high linoleic acid diet exacerbates metabolic responses and gut microbiota dysbiosis in obese rats with diabetes mellitus, Food Func. 10(2) (2019) 786–798. https://doi.org/10.1039/c8fo02423e.

[42]

L.J. Zhao, H.X. Lou, Y. Peng, et al., Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications, Endocrine 66(3) (2019) 526–537. https://doi.org/10.1007/s12020-019-02103-8.

[43]

N. Larsen, F.K. Vogensen, F.W.J. van den Berg, et al., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults, PLoS One 5(2) (2010) 10. https://doi.org/10.1371/journal.pone.0009085.

[44]

F. Magne, M. Gotteland, L. Gauthier, et al., The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 12(5) (2020) 1474. https://doi.org/10.3390/nu12051474.

[45]

S.H. Kim, C.S. Huh, I.D. Choi, et al., The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo, J. Appl. Microbiol. 117(3) (2014) 834–845. https://doi.org/10.1111/jam.12573.

[46]

S.E. Pryde, S.H. Duncan, G.L. Hold, et al., The microbiology of butyrate formation in the human colon, Fems Microbiol. Lett. 217(2) (2002) 133. https://doi.org/10.1016/S0378-1097(02)01106-0.

[47]

P. Wang, D.T. Li, W.X. Ke, et al., Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice, Int. J. Obes. 44(1) (2020) 213–225. https://doi.org/10.1038/s41366-019-0332-1.

[48]

S. Sharma, D.C. Saxena, C.S. Riar. Changes in the GABA and polyphenols contents of foxtail millet on germination and their relationship with in vitro antioxidant activity, Food Chem. 245 (2018) 863–870. https://doi.org/10.1016/j.foodchem.2017.11.093.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 25 August 2020
Revised: 26 October 2020
Accepted: 26 October 2020
Published: 11 September 2021
Issue date: January 2022

Copyright

© 2021 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Acknowledgements

Acknowledgement

This work was supported by the National Key R&D Program of China (2017YFD0401200), China Agriculture Research System (CARS-07-13.5-A17), General S&T project of Beijing Municipal Commission of Education (KM202010011006), and BTBU Youth Fund (PXM2019_014213_000007). The authors declare no conflict of interest.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return